Skip to Content

UK Edition. Click here for US version.



PDF options:  View Fullscreen   Download PDF

PDF Transcript



Ranitidine 25mg/ml Solution for Injection
Ranitidine hydrochloride
Read all of this leaflet carefully before you start using this medicine
because it contains important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or nurse.
If you get any side effects, talk to your doctor or pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. See section 4.
The name of your medicine is Ranitidine 25mg/ml Solution for Injection but
will be referred to as ‘Ranitidine Injection’ throughout the remainder of this
What is in this leaflet
1. What Ranitidine Injection is and what it is used for
2. What you need to know before you use Ranitidine Injection
3. How to use Ranitidine Injection
4. Possible side effects
5. How to store Ranitidine Injection
6. Contents of the pack and other information
Ranitidine Injection is a solution for injection into a muscle or infusion into a
vein. It contains ranitidine as the active ingredient. Ranitidine Injection belongs
to a group of medicines called histamine H2 antagonists, which reduce the
amount of acid in your stomach.
For adults (including older people) Ranitidine is used to:
• treat and stop ulcers in the stomach, or the part of the gut it empties into
(the duodenum)
• stop ulcers from bleeding
• improve problems caused by acid in the food pipe (oesophagus) or too
much acid in the stomach. Both of these can cause pain or discomfort
sometimes known as ‘indigestion’, ‘dyspepsia’ or ‘heartburn’
• stop acid coming up from the stomach while under anaesthetic during an
For children (6 months to 18 years) Ranitidine is used to:
• treat ulcers in the stomach, or the part of the gut it empties into (the
• treat and stop problems caused by acid in the food pipe (oesophagus) or
too much acid in the stomach.
Do not use Ranitidine Injection
- if you are allergic to Ranitidine or any of the other ingredients of this
medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist or nurse before you are given
Ranitidine Injection if:
• your kidneys are not working properly
• you have a rare illness called porphyria
• you are pregnant or think you may be pregnant
• you are breast-feeding
• you have heart rhythm problems, or a history of heart trouble
• you have had a ulcer in your stomach before
• you have a breathing problem or lung disease
• you have weak immune system
• you suffer from diabetes
• you have stomach cancer
• you are elderly (over the age of 65 years old)
• you experience unintentional weight loss associated with acid indigestion.
Other medicines and Ranitidine Injection
Tell your doctor or pharmacist if you are taking, have recently taken or might
take any other medicines.
Medicines such as:
• warfarin, for thinning your blood
• glipizide, for lowering blood sugar levels
• lidocaine, a local anaesthetic
• propranolol, procainamide or N-acetylprocainamide, for heart problems
• diazepam, for worry or anxiety problems
• phenytoin, for epilepsy (fits)
• theophylline, for breathing problems (asthma)
• atazanavir or delaviridine, for treating HIV infection
• triazolam, for sleep problems
• gefitnib, for lung cancer
• ketoconazole, to treat fungal infections such as thrush
• midazolam or triazolam, to help with sleeping problems. Midazolam is a
medicine that may be given to you (by your doctor) just before you have
an operation.
Pregnancy and breast-feeding:
If you are pregnant or breast-feeding, think you may be pregnant or are
planning to have a baby, ask your doctor or pharmacist for advice before you
are given this medicine.
As with other medicines, it is not recommended that Ranitidine Injection be
used during pregnancy or breast feeding unless absolutely necessary.
Driving and using machines
Ranitidine Injection is unlikely to affect your ability to drive or operate
Rantidine Injection contains sodium and potassium
Ranitidine Injection contains: Less than 1mmol each of sodium and potassium
per ampoule (2ml) i.e. essentially sodium & potassium free.
This medicine will be given by your doctor or nurse in one of the following ways:
• as a single injection into a muscle
• as a slow infusion into a vein. This is where the drug is slowly given to you
over a few minutes
• as a continuous infusion into a vein. This is where the drug is slowly given
to you over a few hours.
Adults (including older people) and adolescents (12 years and over):
The recommended dose is 50 mg every 6 to 8 hours, as a single injection into
a muscle or as a slow injection or an intermittent infusion into a vein.
For slow injection into the vein
When administered slowly into the vein, the medicine is first diluted to a
volume of 20ml and then given over a period of 2 minutes which may be
repeated every 6 to 8 hours.
For intermittent infusion into the vein
25mg of the injection is directly infused into a vein each hour for 2 hours and
may be repeated every 6-8 hours.
Different doses may also be given to you in the muscle or as a slow infusion
or continuous infusion, depending on what condition you are being treated
for. Your doctor will advise you.
Patients with stomach disorders
If you are receiving Ranitidine injection to prevent bleeding stress ulcers
resulting from being seriously ill, or recurrently bleeding pepticulcers, the
injections may be continued until you are able to feed orally again.
For the prevention of bleeding from ulcers in the stomach and intestine in
seriously ill patients, the treatment is initiated with a dose of 50mg of
Ranitidine injected slowly into a vein followed by a continuous infusion of


Continued overleaf

You may be given Ranitidine either in the muscle or by intravenous injection
45-60 minutes before you receive general anaesthesia if it is suspected that
you may develop acid aspiration syndrome (symptoms of laboured breathing
while unconscious and having/or suspected to have vomited).
Older people
Normal dosage is recommended except for elderly patients who have severe
kidney problems.
Use in children and adolescents
Children and infants (6 months to 11 years)
Your doctor will give Ranitidine by a slow injection into a vein at an initial dose
of 2 or 2.5mg/kg over 10 minutes. The maximum dose is 50 mg every 6 or 8
hours. Sometimes treatment may be given by continuous infusion with a
loading dose of 0.45mg/kg followed by an infusion of 0.15mg/kg/hr. It is
usually only given while your child is unable to take Ranitidine by mouth.
For the prevention of stress ulcers in a seriously sick child, the recommended
dose is 1mg/kg (maximum of 50mg) every 6 to 8 hours or 125-250
micrograms/kg/hr by continuous infusion.
Adolescents (12 years and over)
Same dosage as adults.
Kidney Impairment
If your kidneys are not working properly your doctor may give you a lower
Your dose may be halved to 25mg every 6 to 8 hours if you suffer from severe
kidney problems.
If you have the impression that the effect of Ranitidine Injection is too strong
or too weak, talk to your doctor. If you receive too much it is unlikely to cause
any problems.
If you take more Ranitidine Injection than you should
Your doctor or nurse will give you Ranitidine injection so it is unlikely that you
will receive too much. If you think you have been given too much or have
missed a dose, tell your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not
everybody gets them. The side effects below may sometimes happen.
If you have an allergic reaction to this medicine see a doctor immediately.
An allergic reaction may include:
• any kind of skin rash or “hives”, flaking skin, severe itching of the skin,
boils or sore lips, swelling (of the face, eyelids, lips, mouth or tongue),
• sudden wheezing, fluttering or tightness of the chest, chest pain, feeling
faint especially when standing up or collapse.
If you get any of the following side effects, speak to your doctor or nurse
as soon as possible.
Uncommon (may affect up to 1 in 100 people):
• stomach ache (abdominal pain), constipation, feeling sick (nausea).
Rare (may affect up to 1 in 1,000 people):
• skin rash (occasionally severe (red spots/purple spots or rash)) or itching
• changes in liver function tests and kidney function tests (types of blood
Very rare (may affect up to 1 in 10,000 people):
• feeling sick, loss of appetite with or without jaundice (yellow colour of skin
and white of eyes) as this may be due to hepatitis (inflammation / infection
of the liver)
• unusual tiredness, shortness of breath, bruising more easily or other signs
of infection - this could be a sign of blood problems.
• slow or irregular heart beats, stopped heart beat (heart problems)
• severe stomach pain rarely caused by an inflamed pancreas or a change in
the type of stomach pain
• feeling confused
• hallucinations (seeing, feeling or hearing things that are not there)
• feeling low (depression)
• inflamed blood vessels which may cause reddening of areas of skin,
localized pain and tenderness
• blurred vision
• kidney problems (symptoms may include a change in the amount of urine
passed and its colour, vomiting)
• fainting
• headache or dizziness (sometimes severe)
• pains in muscles or joints
• uncontrolled movements. This usually stops once you stop taking this
• hair loss
• if you are a man, breast tenderness, breast enlargement or sexual
impotence. This sexual impotence usually gets better once you stop taking
this medicine
• diarrhoea
• Inflammation of the pancreas (which may cause severe stomach pain).
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme
By reporting side effects you can help provide more information on the safety
of this medicine.
Keep this medicine out of the sight and reach of children.
• do not store above 25°C
• keep the ampoules in the outer carton in order to protect from light.
Incorrect storage may lead to discolouration of your medicine
• do not use this medicine after the expiry date which is stated on the label
and carton. The expiry date refers to the last day of that month
• if it is out of date or you no longer want it, take it back to the pharmacy.
What Ranitidine Injection contains
The active substance is ranitidine hydrochloride. Each 2ml sterile solution for
injection contains 50mg ranitidine (as ranitidine hydrochloride).
The other ingredients are sodium chloride, monopotassium phosphate,
anhydrous disodium phosphate, water for injection and nitrogen.
What Ranitidine Injection looks like and contents of the pack
Ranitidine Injection is a colourless to almost colourless clear liquid.
It comes in glass ampoules each containing 2ml of solution and is packed in
boxes of 5 ampoules each.
Marketing Authorisation Holder
Mercury Pharma International Ltd., 4045, Kingswood Road, City West
Business Park, Co Dublin, Ireland
Delpharm Tours, La Baraudière, 37170, Chambray Lès Tours, France.
This leaflet was last revised in April 2015.



+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.